FEI ZHOU
Broker in Southborough, MA
License number
Massachusetts 9511612
Issued Date
May 2, 2009
Expiration Date
Sep 26, 2011
Type
Salesperson
Address
Address
Southborough, MA 01772
Personal information
See more information about FEI ZHOU at radaris.comName
Address
Phone
6 Jamaicaway Ct, Jamaica Plain, MA 02130
224 Farrwood Dr, Haverhill, MA 01835
Professional information
Pyrrole Derivatives As Dna Gyrase And Topoisomerase Inhibitors
US Patent:
2008016, Jul 3, 2008
Filed:
Feb 16, 2006
Appl. No.:
11/816450
Inventors:
Brian Sherer - Nashua NH, US
Fei Zhou - Southborough MA, US
Fei Zhou - Southborough MA, US
International Classification:
A61K 31/5377, C07D 207/36, A61K 31/40, C07D 413/02
US Classification:
5142355, 548537, 514423, 544141
Abstract:
Compounds of formula (I) and their pharmaceutically acceptable salts are described: Processes for their preparation, pharmaceutical compositions containing them, their use as medicaments and their use in the treatment of bacterial infections are also described.
3-{4-(Pyridin-3-Yl) Phenyl}-5-(1H-1,2,3-Triazol-1-Ylmethyl)-1,3-Oxazolidin-2-Ones As Antibacterial Agents
US Patent:
2008002, Jan 24, 2008
Filed:
May 24, 2005
Appl. No.:
11/569208
Inventors:
Michael Gravestock - Holliston MA, US
Folkert Reck - Sudbury MA, US
Fei Zhou - Southborough MA, US
Folkert Reck - Sudbury MA, US
Fei Zhou - Southborough MA, US
Assignee:
ASTRAZENECA AB - Sodertalje
International Classification:
A61K 31/4439, A61K 31/443, A61P 31/04, C07D 413/14
US Classification:
514340000, 546271400
Abstract:
Compounds of formula (I), as well as pharmaceutically-acceptable salts and pro-drugs thereof, are disclosed wherein R, R, R, and Rare defined herein. Also disclosed are processes for making compounds of formula (I) as well as methods of using compounds of formula (I) for treating bacterial infections.
3-[4-{6-Substituted Alkanoyl Pyridin-3-Yl}-3-Phenyl]-5-(1H-1,2,3-Triazol-1-Ylmethyl)-1,3-Oxazolidin-2-Ones As Antibacterial Agents
US Patent:
2008002, Jan 24, 2008
Filed:
May 24, 2005
Appl. No.:
11/569408
Inventors:
Michael Gravestock - Holliston MA, US
Folkert Reck - Sudbury MA, US
Fei Zhou - Southborough MA, US
Folkert Reck - Sudbury MA, US
Fei Zhou - Southborough MA, US
Assignee:
ASTRAZENECA AB - Sodertalje
International Classification:
A61K 31/397, A61K 31/4439, A61K 31/4523, A61K 31/5377, A61P 31/04, C07D 205/02, C07D 213/02, C07D 221/00, C07D 295/00
US Classification:
514210180, 514236200, 514253100, 514318000, 514340000, 514341000, 544124000, 544364000, 546193000, 546271400
Abstract:
Compounds of formula (I) as well as pharmaceutically-acceptable salts and pro-drugs thereof are disclosed wherein R, R, R, and Rare defined herein. Also disclosed are processes for making compounds of formula (I) as well as methods of using compounds of formula (I) for treating bacterial infections.
Antibacterial Piperdine Derivatives
US Patent:
8399489, Mar 19, 2013
Filed:
Feb 16, 2006
Appl. No.:
11/816612
Inventors:
Gregory Basarab - Sudbury MA, US
Brian Dangel - Somerville MA, US
Paul Robert Fleming - Waltham MA, US
Michael Barry Gravestock - Holliston MA, US
Oluyinka Green - Burlington MA, US
Sheila Irene Hauck - Waltham MA, US
Pamela Hill - Waltham MA, US
Kenneth Gregory Hull - Marlborough MA, US
George Mullen - Wilmington NC, US
Haihong Ni - Lexington MA, US
Brian Sherer - Nashua NH, US
Fei Zhou - Southborough MA, US
Brian Dangel - Somerville MA, US
Paul Robert Fleming - Waltham MA, US
Michael Barry Gravestock - Holliston MA, US
Oluyinka Green - Burlington MA, US
Sheila Irene Hauck - Waltham MA, US
Pamela Hill - Waltham MA, US
Kenneth Gregory Hull - Marlborough MA, US
George Mullen - Wilmington NC, US
Haihong Ni - Lexington MA, US
Brian Sherer - Nashua NH, US
Fei Zhou - Southborough MA, US
Assignee:
Astrazeneca AB - Macclesfield, Cheshire
International Classification:
A61K 31/454, C07D 401/14
US Classification:
514326, 546208
Abstract:
Compounds of formula (I) and their pharmaceutically acceptable salts are described. Processes for their preparation, pharmaceutical compositions containing them, their use as medicaments and their use in the treatment of bacterial infections are also described.